Opinion
Video
Author(s):
A comprehensive discussion surrounding the clinical development of PSMA-targeted therapies for patients with prostate cancer.
Healthy diet may lower risk of grade reclassification in patients with GG1 prostate cancer
Dr. Murphy on increasing diversity in cancer clinical trials
PACE-B trial: Five-fraction SBRT noninferior to conventional radiotherapy in prostate cancer
Dr. Schwen on focal therapies for prostate cancer
Lisa F. Newcomb, PhD, on active surveillance for prostate cancer
Nivolumab plus SOC associated with improved FFBR in GG5 prostate cancer